Friday, September 30, 2022


Biotechnology News Magazine

Varigard, LLC Awarded 3-Year Agreement With MAGNET GROUP

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Varigard, LLC has announced a three-year agreement with Mid-Atlantic Group Network of Shared Services Cooperative, also known as “MAGNET GROUP”, one of the oldest non-profit cooperative group purchasing and shared services organizations in the country.

Varigard brings together the latest in advanced polymer technologies and personal protection products to deliver pathogen protection that has not been seen before in the medical community. All of Varigard’s formulated product lines have been proven to sequester pathogens on contact including SARS-CoV-2.

“Varigard’s agreement will provide patented hand sanitizing lotions and surface counter disinfectants with extended protection times for MAGNET GROUP member facilities. Through strategic partnerships, Varigard also offers MAGNET GROUP members innovative products aimed at controlling airborne pathogens. We are excited about the partnership with MAGNET GROUP and look forward to delivering these game-changing solutions for years to come.” Michael Paolillo, CEO, Varigard, LLC

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine